15th International Conference on Malignant Lymphoma


June 18-22, 2019 Lugano
Virtual Poster Gallery

Tel.: +34 91 736 2385
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:30 Fri 8:30-15:00
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
Captcha image


15th International Conference on Malignant Lymphoma


June 18-22, 2019 Lugano
Most-visited poster
from congress
Volver a la portada del congreso

   136-159 | 160-190 | 192-214 | 215-244 | 246-280 | ...  Next range
posters found | 102
Poster no.
Poster/abstract title
Presentation date and time
P-246 REAL-WORLD RESULTS ON CD19 CAR T-CELL FO.. Catherine Thieblemont .. .. IMMUNOTHERAPY.. - -
P-247 Safety and Preliminary Efficacy in Patie.. Michael Wang .. .. IMMUNOTHERAPY.. - -
P-249 Safety and Efficacy of Axicabtagene Cilo.. Dahlia Sano .. .. IMMUNOTHERAPY.. - -
P-251 Phase 1 Study of AntiCD19 CAR-T Cells wi.. Paolo Caimi .. J Reese, F Otegbeye, D Schneid.. IMMUNOTHERAPY.. - -
P-252 CD19/CD20-redirected bispecific CAR T ce.. Yao Wang .. Zhiqiang Wu, Chuan Tong, Wen-y.. IMMUNOTHERAPY.. - -
P-256 Clinical Implications of Cytopenias Beyo.. Paolo Strati .. .. IMMUNOTHERAPY.. - -
P-257 Comprehensive report of anti-CD19 chimer.. Kartik Anand .. Dr. Swaminathan Iyer, Dr. Neel.. IMMUNOTHERAPY.. - -
P-258 Safety of Allogeneic Hematopoietic Cell .. Mazyar Shadman .. .. IMMUNOTHERAPY.. - -
P-259 Title: Clinical and Biological Evaluatio.. Ahmed Sawas .. .. IMMUNOTHERAPY.. - -
P-260 Ipilimumab plus Lenalidomide for Treatme.. Issa Khouri .. .. IMMUNOTHERAPY.. - -
P-261 Donor lymphocyte infusions induce durabl.. Stephen Robinson .. .. IMMUNOTHERAPY.. - -
P-267 Reversal of immune tolerance and increas.. Isabel Jiménez .. .. NOVEL TREATMENTS.. - -
P-269 The novel bispecific CD47-CD19 antibody .. Emmanuel Normant .. .. NOVEL TREATMENTS.. - -
P-271 Preliminary results of a Phase 1 dose es.. Arturo Molina .. Shannon MathenyNirav Shah.. NOVEL TREATMENTS.. - -
P-272 Long-term outcome of patients with relap.. Vera Dufner .. .. NOVEL TREATMENTS.. - -
P-273 A first-in-human trial of the novel mult.. Antonello Pinto .. Please note that 41798513253 i.. NOVEL TREATMENTS.. - -
P-277 Safety and efficacy of venetoclax combin.. Paolo Caimi .. J Jagadeesh, K Boughan, R Dean.. NOVEL TREATMENTS.. - -
P-278 Feasibility and Benefit of Molecularly-I.. Jean-Marie Michot .. .. NOVEL TREATMENTS.. - -
P-279 Safety and early data from a phase II tr.. David Sermer .. .. NOVEL TREATMENTS.. - -
P-280 Safety and efficacy of atezolizumab, obi.. Charles Herbaux .. .. NOVEL TREATMENTS.. - -
Logo Cert
Close abstract


Thunderstorm-related asthma in patients sensitised to olea europaea pollen: twenty emergency department visits for asthmatic symptoms in one single day Losappio, Laura1; Heffler, Enrico2; Falco, Antonio1; Contento, Francesco1; Cannito, Cosimo1; Rolla, Giovanni2 1"Dimiccoli" Hospital, Emergency Department, Barletta, Italy; 2University of Torino - AO Mauriziano "Umberto I", Allergy and Clinical Immunology, Torino, Italy

Background: Associations between thunderstorm and asthma morbidity have been reported in several countries. Common to all epidemics of thunderstorm-related asthma is a significant increase in atmospheric allergen load during and immediately after a thunderstorm. Sensitization to Alternaria species or to grass and parietaria pollens has been suggested to play a key role in thunderstorm-related asthma. The only reported event of thunderstorm-related asthma in Mediterranean area was attributed to sensitization to parietaria pollen.

Method: here we describe a series of 20 patients who presented to Emergency Department in Barletta (94,000 inhabitants), Puglia (Italy) for sudden and severe asthmatic symptoms between May 27th and 28th 2010 (from15:36 to 5:02), immediately after a violent thunderstorm which occurred following a very hot morning (mean temperature: 29°C). All the patients have been subsequently visited by an allergist and underwent allergological work-up which included skin prick tests and a careful clinical history. Local pollen counts were available.

Result: Between May 10th and June 10th 2010, 86 Emergency Department asthma visits were recorded, 20 of them during the study day. Patients' mean age was 44.25 +/- 18.5 years (range: 9-81), 8/20 females, 2 smokers, 16 with a previous history of known respiratory allergy. Only two patients regularly took anti-asthma drugs. All 20 patients were sensitized to Olea europaea pollen, 7 of whom were monosensitized. Ten patients were sensitized to grass, 7 to parietaria, 5 to compositae, 5 to cypress, 5 to house dust mites, 3 to dog and 1 to cat danders. No patient was sensitized to Alternaria. Mean pollen count was 17 granules/m3 for Olea europaea, 6 granules/m3 for grass pollen.

Conclusion: This is, in our knowledge, the second epidemic of thunderstorm related asthma described in Mediterranean area and the first one in which sensitization to Olea europaea played a key-role. In conclusion, our report indicates that thunderstorm asthma may involve different allergens (not only fungal spores and grass or parietaria pollen) in different geographic areas, depending on the seasonality of thunderstorms and allergenic pollen.

Close poster